Fig. 1From: A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancerBest response for evaluable subjects (n = 45). PR = Partial Response; SD = Stable Disease; PD = Progressive DiseaseBack to article page